Bioequivalence Study of Ramipril 10 mg Capsules Under Fed Conditions
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The study was conducted as an open label, balanced, randomized, two-treatment, two-period,
two-sequence, single-dose, crossover bioavailability study comparing ramipril 10 mg capsules
of Ohm Laboratories Inc., with Altace® capsule 10 mg (containing ramipril 10 mg) manufactured
by King Pharmaceuticals Inc, Bristol and Distributed by Monarch Pharmaceuticals Inc, Bristol
in healthy, adult, male, human subjects under fed condition.